Kemps-Polanco Reshema bought CRL
February 1, 2024 · Form 4 insider transaction
Kemps-Polanco Reshema bought 170 shares of Charles River Laboratories International, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
170
Price
$0.00
Total value
N/A
InsiderKemps-Polanco Reshema
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 1, 2024
Filing dateFebruary 5, 2024
Shares owned after170
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of 170 unvested restricted stock units that vest on 5/7/2024.